Sumitomo's Presidio Ventures unit has contributed to the $56.2m in debt and equity financing so far raised by the robot arm developer.

Dexterity, a logistics robot spinout of Stanford, has emerged from stealth with series A funding and debt financing from Stanford-StartX Fund.

Scalable Capital is valued in excess of $460m following a Tengelmann-backed round that lifted the digital wealth manager's total funding to about $130m.

The CNS disease therapy developer raised a further $20m, adding to a $45m close in April that included GV and Takeda Ventures.

The real estate investment manager is now the largest investor in Harel Group-backed Ecoppia, which provides solar-panel cleaning systems.

UPMC Enterprises has contributed to a $20m series B extension for Cerevance, which is commercialising Rockefeller University research.

Fidelity led a series C round for haematology and cancer therapy developer Antengene, whose corporate shareholders include Celgene, Taikang, Tigermed and WuXi AppTec.

NYU-founded Spin Memory has now raised $60.3m in series B capital, having lured the return of Allied Minds, Arm and Applied Ventures.

Alphabet and EmblemHealth returned to help supply $53.5m for the community-focused care provider, bringing its overall funding to nearly $140m.

Adimab's coronavirus antibody spinoff has launched with series A financing from investors including GV as it prepares for its first clinical trials.